Hyseq has appointed William Bennett as senior vice president of research.
Bennett previously worked with Hyseq CEO Ted Love at Genentech, where he served as team leader of the TNKase project and held numerous other R&D positions.
Since leaving Genentech, Bennett has held the positions of senior vice president, research and manufacturing at Sensus Drug Development, senior vice president for product development at BigBearBio, and vice president of research at COR Therapeutics.
Bennett received his PhD from University of Texas Southwestern Medical School, has authored 50 scientific publications, and holds 19 issued US patents.
At Sunnyvale, Calif.-based Hyseq, which has shifted its main focus recently from biochips to biopharmaceuticals (see p. 5), Bennett said he is planning to work on implementing the new strategy.
“Hyseq has discovered a large number of novel genes and the next step is moving candidates into the clinic. This is an important time in the company’s strategy of building a biopharmaceutical company and I look forward to playing a leading role,” Bennett said in a statement.